Unit
- Diabetes mellitus: A chronic metabolic disorder characterized by elevated blood glucose levels due to defects in insulin secretion, insulin action, or both. It leads to long-term damage to organs including eyes, kidneys, nerves, and blood vessels.
- Global burden: According to the International Diabetes Federation, approximately 537 million adults aged 20-79 years had diabetes in 2021, with projections reaching 783 million by 2045. The disease contributes to over 6.7 million deaths annually.
- Economic impact: Diabetes imposes substantial healthcare costs, estimated at over $966 billion globally in 2021. This includes direct medical expenses and indirect costs from lost productivity and premature disability.
- Regional variation: Prevalence is highest in the Middle East and North Africa (16.2%) and lowest in Africa (5.9%). Urbanization, aging populations, and lifestyle changes drive increasing rates in low- and middle-income countries.
- Key risk factors: Modifiable factors include physical inactivity, unhealthy diet, obesity (especially central adiposity), and smoking. Non-modifiable factors include age, family history, ethnicity (higher risk in South Asian, African, and Hispanic populations), and genetic predisposition.
- Diagnostic criteria: Fasting plasma glucose at or above 126 mg/dL; 2-hour plasma glucose at or above 200 mg/dL during an oral glucose tolerance test; hemoglobin A1c at or above 6.5 percent; or random plasma glucose at or above 200 mg/dL with classic symptoms of hyperglycemia.
- Type 1 versus type 2: Type 1 diabetes results from autoimmune destruction of pancreatic beta cells, usually presenting in youth and requiring lifelong insulin. Type 2 diabetes involves insulin resistance and relative insulin deficiency, often associated with obesity and developing in adults, though increasingly seen in younger populations.
- Gestational diabetes: Glucose intolerance first recognized during pregnancy, affecting approximately 7-14% of pregnancies globally. It increases the risk of adverse maternal and fetal outcomes and later development of type 2 diabetes in both mother and child.
- Public health initiatives: Prevention programs focus on lifestyle modification, early screening for high-risk individuals, and community awareness campaigns. The World Health Organization target is to halt the rise in diabetes by 2025.
- Healthcare system role: Diabetes management requires integrated care models with primary care, specialists, diabetes educators, dietitians, and pharmacists. Administrative staff coordinate referrals, track lab results, and facilitate patient education.
- Complications: Chronic hyperglycemia leads to microvascular complications including retinopathy, nephropathy, and neuropathy, and macrovascular complications such as cardiovascular disease, stroke, and peripheral artery disease. Strict glycemic control reduces the risk of microvascular complications by 35 to 40 percent and is also beneficial for macrovascular outcomes.
- Treatment goals: Management of diabetes aims to achieve near-normal blood glucose levels while minimizing the risk of hypoglycemia. Individualized hemoglobin A1c targets are typically set below 7 percent for most nonpregnant adults, with less stringent goals for patients with advanced complications or limited life expectancy. Regular monitoring and medication adjustments are essential.
- Self-management education: Diabetes self-management education and support is a critical component of care. It helps patients develop skills for blood glucose monitoring, medication adjustment, healthy eating, and physical activity. Programs that include behavioral strategies and ongoing support show improved glycemic outcomes and reduced hospitalizations.
Regulatory Note
Regulation: The Diagnostic Criteria for Diabetes Mellitus are standardized by the American Diabetes Association (ADA) and endorsed by the World Health Organization. These guidelines ensure consistent diagnosis across healthcare settings and form the basis for insurance coverage and public health reporting.
ADA Standards of Medical Care in Diabetes, annually updated.
Quick Revision
- Diabetes is a chronic metabolic disorder with elevated blood glucose caused by insulin deficiency or resistance.
- Global prevalence is rising, with significant economic and health burdens.
- Diagnostic criteria include fasting glucose, OGTT, A1c, or random glucose with symptoms.
- Public health efforts and integrated care models are essential for prevention and management.